Screening and Identification of a Novel Anti-Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity.
Wu J, Peng J, Zhou Y, Zhang R, Wang Z, Hu N, Zhang D, Quan G, Wu Y, Feng J, Shen B, Zhao J, Zhang Y, Yang K, Luo L.
Wu J, et al. Among authors: zhang r, zhang d, zhang y.
Mol Pharmacol. 2022 Sep;102(3):161-171. doi: 10.1124/molpharm.121.000470. Epub 2022 Jun 28.
Mol Pharmacol. 2022.
PMID: 35764384